News
Insight Enterprises, Inc. Reports Second Quarter Results
Insight Enterprises, Inc. (NASDAQ: NSIT) (the “Company”) today reported financial results for the quarter ended June 30, 2025. Results include:
-
Consolidated net sales decreased 3%, year to year
Reply S.p.A.: the Board of Directors Approves the Half-Year Financial Report as of 30 June 2025
Today, the Board of Directors of Reply S.p.A. [EXM, STAR: REY] approved the results as at 30 June 2025.
Since the start of the year, the Group has recorded a consolidated turnover of €1,210.1
Amphenol Announces Third Quarter 2025 Dividend
Amphenol Corporation (NYSE: APH) announced today that its Board of Directors approved the third quarter 2025 dividend on its Common Stock in the amount of $0.165 per share at its meeting held on
Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.
Form 8.3 - The Vanguard Group, Inc.: Dalata Hotel Group plc
Form 8.3 - The Vanguard Group, Inc.: Greencore Group plc
Form 8.3 - The Vanguard Group, Inc.: Primary Health Properties plc
Form 8.3 - The Vanguard Group, Inc.: Assura plc
Form 8.3 - The Vanguard Group, Inc.: Deliveroo plc
Form 8.3 - The Vanguard Group, Inc.: Dowlais Group plc
Form 8.3 - The Vanguard Group, Inc.: Tritax Big Box REIT plc
Form 8.3 - The Vanguard Group, Inc.: Bakkavor Group plc
Form 8.3 - The Vanguard Group, Inc.: NCC Group plc
Form 8.3 - The Vanguard Group, Inc.: Unite Group plc, The
Form 8.3 - The Vanguard Group, Inc.: Mitie Group plc
Form 8.3 - The Vanguard Group, Inc.: Spectris plc
EQS-News: Shelly Group: Invitation to unaudited 6M 2025 earnings webcast/call on 15 August2025
EQS-News: MEDICLIN reports positive interim results for the first half of 2025
EQS-News: The Platform Group raises its sales and earnings forecast for 2025 – Increase in medium-term planning
EQS-Adhoc: The Platform Group AG raises sales and earnings forecast for 2025 – Increase in medium-term planning
Sensorion Announces Its Participation In Upcoming Investor Conferences
Regulatory News:
Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss
EQS-News: Logwin reports volume-driven increase in revenue in the first half of 2025
Coinsilium Group Limited: Total Voting Rights
Fluidra Delivers a Strong First Half, With Sales up 5% to €1,227 Million and Growth Across All Regions
Fluidra, the global leader in equipment and connected solutions in the pool and wellness sector, achieved sales of €1,227 million in the first half of 2025, up 5% year-on-year with growth across



